EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines (Q40008366)

16 September 2017

title

EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines (English)

1 reference

16 September 2017

1 reference

1 reference

G J Weiss

1

1 reference

16 September 2017

L T Bemis

2

1 reference

16 September 2017

E Nakajima

3

1 reference

16 September 2017

M Sugita

4

1 reference

16 September 2017

D K Birks

5

1 reference

16 September 2017

W A Robinson

6

1 reference

16 September 2017

M Varella-Garcia

7

1 reference

16 September 2017

P A Bunn

8

1 reference

16 September 2017

J Haney

9

1 reference

16 September 2017

B A Helfrich

10

1 reference

16 September 2017

H Kato

11

1 reference

16 September 2017

F R Hirsch

12

1 reference

16 September 2017

W A Franklin

13

1 reference

16 September 2017

language of work or name

1 reference

27 February 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

19

1 reference

16 September 2017

issue

6

1 reference

16 September 2017

page(s)

1053-1059

1 reference

Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

Selecting lung cancer patients for treatment with epidermal growth factor receptor tyrosine kinase inhibitors by immunohistochemistry and fluorescence in situ hybridization--why, when, and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

Epidermal growth factor receptor mutations in lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

Impaired microRNA processing enhances cellular transformation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

MicroRNA and lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

Spectral karyotype (SKY) analysis of human prostate carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

Lineage-specific gene duplication and loss in human and great ape evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

RAS is regulated by the let-7 microRNA family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

Retrospective analysis of the predictive factors associated with the response and survival benefit of gefitinib in patients with advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

Gefitinib monotherapy in advanced nonsmall cell lung cancer: a large Western community implementation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN006

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDN006

1 reference

release_l7bc7xe3jzd3rkgca67s46dwoy

16 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/l7bc7xe3jzd3rkgca67s46dwoy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference